Waters Corp (WAT)

$409.38 -4.18 (-1.01%)
Market Cap 40.22B
Revenue (ttm) 3.17B
Net Income (ttm) 642.63M
EPS (ttm) N/A
PE Ratio 29.93
Forward PE 28.11
Profit Margin 20.30%
Debt to Equity Ratio 0.32
Volume 352,000
Avg Vol 824,114
Day's Range N/A - N/A
Shares Out 98.25M
Stochastic %K 28%
Beta 1.19
Analysts Strong Sell
Price Target $443.45

Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 508 478 2000
Fax: 508 872 1990
Address:
34 Maple Street, Milford, United States
TalkMarkets
TalkMarkets Sep. 4 at 11:45 PM
AskSlim Market Week - Friday, Sep. 5 $HYG $TSLA $CRWD $WAT $TMO https://talkmarkets.com/article/askslim-market-week---friday-sep-5-1788565471
0 · Reply
topstockalerts
topstockalerts Aug. 31 at 8:12 PM
Morgan Stanley analysts view Waters Corporation as the best-positioned life sciences diagnostics company following China’s release of its final pricing framework for clinical laboratory services. The framework covers 662 core items, 114 add-ons and seven extensions, maintaining differentiated treatment for advanced workflows such as mass spectrometry and introducing tiered discounts for multi-test panels. Waters benefits from its exposure to mass spectrometry and complex microbiology workflows, which retain premium treatment under the new rules. Morgan Stanley called the framework constructive for both clinical mass spectrometry and microbiology, while Waters said preserved surcharges should support adoption by recognizing the clinical value of quantitative testing. For Danaher, the framework largely matches management’s prior expectations. Routine chemistry and immunoassays face standardized pricing and pressure on hospital lab economics. $WAT
0 · Reply
JFDI
JFDI Aug. 30 at 7:40 PM
$WAT CC @aaxaa
0 · Reply
Chico1234
Chico1234 Aug. 29 at 1:10 PM
$WAT I’d rather let the results do the talking
0 · Reply
JackCoLu
JackCoLu Aug. 27 at 8:46 PM
$WAT Healthcare company that hasn't really been looked at. I'm in for 50 shares!
0 · Reply
SilverEagle
SilverEagle Aug. 27 at 6:35 PM
$WAT this monthly is looking pretttty. Outsized move incoming.
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 27 at 5:01 PM
$WAT printed a new 52-week high today
0 · Reply
STRelativeStrength
STRelativeStrength Aug. 27 at 4:05 PM
$WAT undiscovered breakout with 772 watchers
0 · Reply
OnlyFibs
OnlyFibs Aug. 23 at 12:21 AM
$WAT | Waters Corp. (Healthcare / Life Sciences Tools 📢) $WAT is pushing directly into all-time high resistance around $415.00–$421.74 after breaking out off the $357.00 volume shelf. The 1W chart shows heavy volume profile acceptance holding as price coils tightly under its macro range boundary. Key Technical Levels: • Confirmation Trigger: $421.75 🚀 • Pivot Support: $400.00 🐂 • Overhead Target 1: $435.00 🎯 • Overhead Target 2: $450.00 💰 • Downside Risk Level: $357.00 🐻 • Stop Loss: $388.00 🔴 Flow & Market Bias: Structure: 1W Range Compression / ATH Resistance Test Bias: Bullish above $400.00 #WAT #optionsflow #stockmarket #technicalanalysis #swingtrading #hovdid
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 20 at 7:31 PM
$WAT printed a new 52-week high today
0 · Reply
Latest News on WAT
LetsGetChecked Powered by Fuze Health Partners with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients

Aug 27, 2026, 10:00 AM EDT - 11 days ago

LetsGetChecked Powered by Fuze Health Partners with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients

Piper upgrades Waters to Overweight on replacement cycle

2026-08-27T10:35:58.000Z - 11 days ago

Piper upgrades Waters to Overweight on replacement cycle

Waters upgraded to Overweight from Neutral at Piper Sandler

2026-08-27T09:40:10.000Z - 11 days ago

Waters upgraded to Overweight from Neutral at Piper Sandler

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Aug 26, 2026, 9:00 AM EDT - 12 days ago

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Waters price target raised to $470 from $425 at Citi

2026-08-10T10:46:26.000Z - 4 weeks ago

Waters price target raised to $470 from $425 at Citi

Waters price target raised to $430 from $390 at Morgan Stanley

2026-08-05T18:00:37.000Z - 4 weeks ago

Waters price target raised to $430 from $390 at Morgan Stanley

Waters price target raised to $475 from $435 at RBC Capital

2026-08-05T14:27:03.000Z - 4 weeks ago

Waters price target raised to $475 from $435 at RBC Capital

Waters price target raised to $420 from $410 at Evercore ISI

2026-08-05T14:19:43.000Z - 4 weeks ago

Waters price target raised to $420 from $410 at Evercore ISI

Waters price target raised to $400 from $380 at Deutsche Bank

2026-08-05T13:48:55.000Z - 4 weeks ago

Waters price target raised to $400 from $380 at Deutsche Bank

Waters price target raised to $420 from $380 at Stifel

2026-08-05T11:17:47.000Z - 4 weeks ago

Waters price target raised to $420 from $380 at Stifel

Waters upgraded to Buy from Hold at TD Cowen

2026-08-05T09:40:29.000Z - 4 weeks ago

Waters upgraded to Buy from Hold at TD Cowen

Waters price target raised to $460 from $425 at Barclays

2026-08-05T09:25:25.000Z - 4 weeks ago

Waters price target raised to $460 from $425 at Barclays

Waters Earnings Call Transcript: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 4 weeks ago

Waters Earnings Call Transcript: Q2 2026

Waters Earnings release: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 4 weeks ago

Waters Earnings release: Q2 2026

Waters Slides: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 4 weeks ago

Waters Slides: Q2 2026

Waters Quarterly report: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 4 weeks ago

Waters Quarterly report: Q2 2026

Waters sees Q3 adjusted EPS $3.95-$4.05, consensus $3.99

2026-08-04T11:17:31.000Z - 4 weeks ago

Waters sees Q3 adjusted EPS $3.95-$4.05, consensus $3.99

Waters raises FY26 adjusted EPS view to $14.45-$14.65 from $14.40-$14.60

2026-08-04T11:16:54.000Z - 4 weeks ago

Waters raises FY26 adjusted EPS view to $14.45-$14.65 from $14.40-$14.60

Waters reports Q2 adjusted EPS $3.05, consensus $3.01

2026-08-04T11:11:00.000Z - 4 weeks ago

Waters reports Q2 adjusted EPS $3.05, consensus $3.01

Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results

Aug 4, 2026, 6:00 AM EDT - 4 weeks ago

Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Jul 27, 2026, 8:10 AM EDT - 6 weeks ago

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Waters price target raised to $408 from $385 at TD Cowen

2026-07-15T12:45:32.000Z - 7 weeks ago

Waters price target raised to $408 from $385 at TD Cowen

Waters price target raised to $425 from $380 at Goldman Sachs

2026-07-14T10:16:10.000Z - 7 weeks ago

Waters price target raised to $425 from $380 at Goldman Sachs

Waters price target raised to $390 from $350 at Morgan Stanley

2026-07-09T11:05:53.000Z - 2 months ago

Waters price target raised to $390 from $350 at Morgan Stanley

Waters initiated with an Outperform at RBC Capital

2026-07-08T20:45:16.000Z - 2 months ago

Waters initiated with an Outperform at RBC Capital

Waters price target raised to $410 from $380 at Evercore ISI

2026-07-06T12:50:31.000Z - 2 months ago

Waters price target raised to $410 from $380 at Evercore ISI

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

Jul 2, 2026, 6:00 AM EDT - 2 months ago

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

Waters resumed with an Outperform at Bernstein

2026-06-26T10:30:51.000Z - 2 months ago

Waters resumed with an Outperform at Bernstein

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Jun 24, 2026, 8:00 AM EDT - 2 months ago

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis

Jun 9, 2026, 8:00 AM EDT - 3 months ago

Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Jun 8, 2026, 8:00 AM EDT - 3 months ago

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Waters Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 10:30 AM EDT - 3 months ago

Waters Transcript: Jefferies Global Healthcare Conference 2026

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

Jun 3, 2026, 8:00 AM EDT - 3 months ago

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Jun 1, 2026, 8:00 AM EDT - 3 months ago

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Jun 1, 2026, 8:00 AM EDT - 3 months ago

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Corporation to Present at the Jefferies Global Healthcare Conference

May 18, 2026, 4:00 PM EDT - 3 months ago

Waters Corporation to Present at the Jefferies Global Healthcare Conference

Waters CEO highlights China as key innovation source in the biopharma market

May 5, 2026, 6:47 PM EDT - 4 months ago

Waters CEO highlights China as key innovation source in the biopharma market

Waters raises annual profit forecast as biosciences unit drives growth

May 5, 2026, 10:38 AM EDT - 4 months ago

Waters raises annual profit forecast as biosciences unit drives growth

Waters Earnings Call Transcript: Q1 2026

May 5, 2026, 8:30 AM EDT - 4 months ago

Waters Earnings Call Transcript: Q1 2026

Waters Slides: Q1 2026

May 5, 2026, 8:30 AM EDT - 4 months ago

Waters Slides: Q1 2026

Waters Earnings release: Q1 2026

May 5, 2026, 8:30 AM EDT - 4 months ago

Waters Earnings release: Q1 2026

Waters Quarterly report: Q1 2026

May 5, 2026, 8:30 AM EDT - 4 months ago

Waters Quarterly report: Q1 2026

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

May 5, 2026, 6:00 AM EDT - 4 months ago

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

Apr 20, 2026, 4:15 PM EDT - 4 months ago

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Apr 14, 2026, 8:00 AM EDT - 4 months ago

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Waters Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 5 months ago

Waters Proxy statement: Proxy filing

Waters Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 5 months ago

Waters Proxy statement: Proxy filing

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Apr 8, 2026, 8:00 AM EDT - 5 months ago

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Waters Prices Offering of Senior Notes

Mar 18, 2026, 6:00 AM EDT - 5 months ago

Waters Prices Offering of Senior Notes

Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed

Mar 9, 2026, 8:00 AM EDT - 6 months ago

Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed

Waters Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 11:10 AM EST - 6 months ago

Waters Transcript: TD Cowen 46th Annual Health Care Conference

Waters Corporation to Present at the TD Cowen Health Care Conference

Feb 23, 2026, 4:45 PM EST - 6 months ago

Waters Corporation to Present at the TD Cowen Health Care Conference

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

Feb 17, 2026, 8:00 AM EST - 6 months ago

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

Feb 9, 2026, 8:40 AM EST - 7 months ago

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

BDX

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

Feb 9, 2026, 8:40 AM EST - 7 months ago

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

BDX

Waters Earnings Call Transcript: Q4 2025

Feb 9, 2026, 8:30 AM EST - 7 months ago

Waters Earnings Call Transcript: Q4 2025

Waters Annual report: Q4 2025

Feb 9, 2026, 8:30 AM EST - 7 months ago

Waters Annual report: Q4 2025

Waters Earnings release: Q4 2025

Feb 9, 2026, 8:30 AM EST - 7 months ago

Waters Earnings release: Q4 2025

Waters Slides: Q4 2025

Feb 9, 2026, 8:30 AM EST - 7 months ago

Waters Slides: Q4 2025

Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 9, 2026, 6:30 AM EST - 7 months ago

Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

Jan 27, 2026, 9:25 AM EST - 7 months ago

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

BDX

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

Jan 27, 2026, 9:25 AM EST - 7 months ago

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

BDX

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Jan 20, 2026, 1:00 PM EST - 7 months ago

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Waters Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 5:15 PM EST - 7 months ago

Waters Transcript: 44th Annual J.P. Morgan Healthcare Conference

Waters Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 5:15 PM EST - 7 months ago

Waters Slides: 44th Annual J.P. Morgan Healthcare Conference

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

Dec 23, 2025, 11:00 AM EST - 8 months ago

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

Waters Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 9:30 AM EST - 9 months ago

Waters Transcript: Jefferies London Healthcare Conference 2025

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

Nov 11, 2025, 2:00 PM EST - 10 months ago

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

Nov 11, 2025, 8:00 AM EST - 10 months ago

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

Waters Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Waters Earnings Call Transcript: Q3 2025

Waters Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Waters Quarterly report: Q3 2025

Waters Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Waters Earnings release: Q3 2025

Waters Slides: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Waters Slides: Q3 2025

Waters Corp raises annual profit forecast on stronger lab equipment demand

Nov 4, 2025, 7:10 AM EST - 10 months ago

Waters Corp raises annual profit forecast on stronger lab equipment demand

Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 6:00 AM EST - 10 months ago

Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results

Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

Oct 13, 2025, 8:05 AM EDT - 10 months ago

Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call

Oct 1, 2025, 12:00 PM EDT - 11 months ago

Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call

Waters Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 4, 2025, 9:30 AM EDT - 1 year ago

Waters Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Waters Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings Call Transcript: Q2 2025

Waters Quarterly report: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Quarterly report: Q2 2025

Waters Earnings release: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings release: Q2 2025

Waters Slides: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Slides: Q2 2025

Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 6:00 AM EDT - 1 year ago

Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results

WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT

Jul 16, 2025, 11:33 AM EDT - 1 year ago

WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT

BDX

Top Stock Movers Now: Autodesk, Fortinet, Waters, and More

Jul 14, 2025, 1:05 PM EDT - 1 year ago

Top Stock Movers Now: Autodesk, Fortinet, Waters, and More

ADSK FTNT

Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal

Jul 14, 2025, 11:20 AM EDT - 1 year ago

Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal

Waters Transcript: M&A Announcement

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Waters Transcript: M&A Announcement

Waters Press release: M&A Announcement

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Waters Press release: M&A Announcement

Waters Slides: M&A Announcement

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Waters Slides: M&A Announcement

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

Jul 14, 2025, 6:15 AM EDT - 1 year ago

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

BDX

Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call

Jul 11, 2025, 4:15 PM EDT - 1 year ago

Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

Jun 17, 2025, 10:00 AM EDT - 1 year ago

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

Waters Transcript: Jefferies Global Healthcare Conference 2025

Jun 4, 2025, 8:45 AM EDT - 1 year ago

Waters Transcript: Jefferies Global Healthcare Conference 2025

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality

May 28, 2025, 8:00 AM EDT - 1 year ago

Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality

Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio

May 21, 2025, 8:00 AM EDT - 1 year ago

Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio

Waters Corp's India business boosted by rush for weight-loss drugs

May 15, 2025, 7:48 AM EDT - 1 year ago

Waters Corp's India business boosted by rush for weight-loss drugs

Waters Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings Call Transcript: Q1 2025

Waters Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Quarterly report: Q1 2025

Waters Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings release: Q1 2025

Waters Slides: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Slides: Q1 2025

Waters raises 2025 profit forecast on resilient demand for lab equipment

May 6, 2025, 7:21 AM EDT - 1 year ago

Waters raises 2025 profit forecast on resilient demand for lab equipment

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance

May 6, 2025, 6:15 AM EDT - 1 year ago

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance

TalkMarkets
TalkMarkets Sep. 4 at 11:45 PM
AskSlim Market Week - Friday, Sep. 5 $HYG $TSLA $CRWD $WAT $TMO https://talkmarkets.com/article/askslim-market-week---friday-sep-5-1788565471
0 · Reply
topstockalerts
topstockalerts Aug. 31 at 8:12 PM
Morgan Stanley analysts view Waters Corporation as the best-positioned life sciences diagnostics company following China’s release of its final pricing framework for clinical laboratory services. The framework covers 662 core items, 114 add-ons and seven extensions, maintaining differentiated treatment for advanced workflows such as mass spectrometry and introducing tiered discounts for multi-test panels. Waters benefits from its exposure to mass spectrometry and complex microbiology workflows, which retain premium treatment under the new rules. Morgan Stanley called the framework constructive for both clinical mass spectrometry and microbiology, while Waters said preserved surcharges should support adoption by recognizing the clinical value of quantitative testing. For Danaher, the framework largely matches management’s prior expectations. Routine chemistry and immunoassays face standardized pricing and pressure on hospital lab economics. $WAT
0 · Reply
JFDI
JFDI Aug. 30 at 7:40 PM
$WAT CC @aaxaa
0 · Reply
Chico1234
Chico1234 Aug. 29 at 1:10 PM
$WAT I’d rather let the results do the talking
0 · Reply
JackCoLu
JackCoLu Aug. 27 at 8:46 PM
$WAT Healthcare company that hasn't really been looked at. I'm in for 50 shares!
0 · Reply
SilverEagle
SilverEagle Aug. 27 at 6:35 PM
$WAT this monthly is looking pretttty. Outsized move incoming.
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 27 at 5:01 PM
$WAT printed a new 52-week high today
0 · Reply
STRelativeStrength
STRelativeStrength Aug. 27 at 4:05 PM
$WAT undiscovered breakout with 772 watchers
0 · Reply
OnlyFibs
OnlyFibs Aug. 23 at 12:21 AM
$WAT | Waters Corp. (Healthcare / Life Sciences Tools 📢) $WAT is pushing directly into all-time high resistance around $415.00–$421.74 after breaking out off the $357.00 volume shelf. The 1W chart shows heavy volume profile acceptance holding as price coils tightly under its macro range boundary. Key Technical Levels: • Confirmation Trigger: $421.75 🚀 • Pivot Support: $400.00 🐂 • Overhead Target 1: $435.00 🎯 • Overhead Target 2: $450.00 💰 • Downside Risk Level: $357.00 🐻 • Stop Loss: $388.00 🔴 Flow & Market Bias: Structure: 1W Range Compression / ATH Resistance Test Bias: Bullish above $400.00 #WAT #optionsflow #stockmarket #technicalanalysis #swingtrading #hovdid
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 20 at 7:31 PM
$WAT printed a new 52-week high today
0 · Reply
RuthNordquist295
RuthNordquist295 Aug. 20 at 7:37 AM
$MSCI $IQV $IBKR $WAT $HMC MSCI benefits from investment indexes and analytics demand, IQVIA benefits from pharmaceutical research and clinical-trial activity, Interactive Brokers benefits from trading and client-asset growth, Waters benefits from analytical and laboratory equipment demand, and Honda benefits from global vehicle demand. I'm watching asset flows, clinical spending, trading volumes, lab demand, and auto sales.
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 12 at 3:31 PM
$WAT printed a new 52-week high today
0 · Reply
ShangVXO
ShangVXO Aug. 11 at 3:51 PM
$WAT Dude, I could see this surprising people
0 · Reply
TalkMarkets
TalkMarkets Aug. 11 at 6:43 AM
BDX: A Dividend King In The Medical Supply Business $BDX Also Mentions: $WAT https://talkmarkets.com/article/bdx-a-dividend-king-in-the-medical-supply-business-1786430481
0 · Reply
IN0V8
IN0V8 Aug. 10 at 6:44 PM
$WAT Opportunity Citigroup raises target price to $470 from $425
0 · Reply
CarolDonaldson311
CarolDonaldson311 Aug. 5 at 6:46 AM
$WAT $ROP $FMX $ADM $HIG Waters leads analytical instruments, Roper Technologies expands software solutions, FEMSA strengthens consumer businesses, ADM benefits from global agricultural demand, and Hartford Financial delivers stable insurance earnings.
0 · Reply
EarningsInsider
EarningsInsider Aug. 4 at 1:17 PM
https://www.marketbeat.com/earnings/reports/2026-8-4-waters-co-stock/ $WAT Waters Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 4 at 10:19 AM
$WAT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.39 down -156.28% YoY • Reported revenue of $1.65B up 113.27% YoY • Waters Corporation raised its full-year 2026 adjusted EPS guidance to $14.45 to $14.65, representing 10-12% growth, while expecting total reported revenue for the full year of $6.415 billion to $6.476 billion.
0 · Reply
prismmarketview
prismmarketview Jul. 20 at 6:57 PM
Women's oncology is entering a new growth phase. A new PwC report projects the market could approach $110 billion by 2030, with investment increasingly expanding beyond breast cancer into ovarian, cervical and endometrial cancers. Our latest examines the trends driving the sector and highlights public companies advancing innovation across earlier detection, targeted therapies and immuno-oncology. $WAT $CORT $VSTM $IMNN $BLRX https://prismmarketview.com/womens-oncology-is-entering-its-next-growth-phase-as-investment-moves-beyond-breast-cancer/
0 · Reply
UpgradeDowngrade
UpgradeDowngrade Jul. 10 at 2:26 PM
$WAT RBC Capital Mkts has altered their rating of "Outperform" and target of "$435" see consensus outlook
0 · Reply
UpgradeDowngrade
UpgradeDowngrade Jun. 30 at 2:29 AM
$WAT Bernstein has altered their rating of "Outperform" and target of "$435" see consensus outlook
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 3:26 PM
$WAT Current Stock Price: $357.98 Contracts to trade: $360.0 WAT Jul 17 2026 Call Entry: $11.90 Exit: $20.68 ROI: 74% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply